ArticleAIDS (London, England)2025
Preferences for HIV preexposure prophylaxis care among gay, bisexual, and other MSM: a large discrete choice experiment.
Article in AIDS (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preferences for HIV pre-exposure prophylaxis among men who have sex with men and trans women in 15 countries and territories in Asia and Australia: a discrete choice experiment.Journal of the International AIDS Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveWe aimed to identify preferences for preexposure prophylaxis (PrEP) care among diverse gay, bisexual, and other MSM (GBM) in the United States with discrete choice experiment (DCE).
designWe conducted two DCEs to elicit care delivery preferences for starting and continuing PrEP among 16-49-year-old GBM who were HIV-negative and not using PrEP from across the United States. DCEs assessed preferences for care options including location, formulation (pills, injectable), lab testing, and costs. Participants completed 16 choice tasks, and utility scores and relative importance were estimated. We performed latent class analyses to identify groups within each DCE, and multivariable logistic regression to identify sociodemographic characteristics associated with class membership.
resultsAmong 1514 participants, 46.5% identified as Latino, 21.4% Black, and 25.2 White. For Starting PrEP DCE, two latent classes were identified: 'In-Person' (28.5%), which preferred in-person care and lab testing, and 'Virtual' (71.5%), which preferred telehealth and at-home lab testing. For Continuing PrEP DCE, two latent classes were identified: 'Pills' (23.6%), which preferred oral PrEP with low-cost options and 'No cost/injectable' (76.4%), which strongly preferred no-costs and injectable PrEP. In multivariable models for Starting PrEP and for Continuing PrEP, latent class membership was significantly associated with a range of sociodemographic characteristics, including race/ethnicity, income, housing instability, and provider and PrEP stigma.
conclusionThe preferences identified for PrEP care in this diverse GBM sample indicate the need for multiple care and formulation choices, including elimination of costs to improve PrEP uptake. DCE findings can guide implementation efforts to improve equitable access to PrEP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.